Management of Lithium-Induced Hypothyroidism
Continue lithium and add levothyroxine replacement therapy rather than discontinuing lithium. This approach preserves the psychiatric benefits of lithium while effectively treating the thyroid dysfunction 1, 2.
Core Management Algorithm
1. Confirm the Diagnosis
- Measure TSH and free T4 levels
- Check thyroid antibodies (present in ~2/3 of cases) 2
- Document lithium level and duration of therapy
- Note: Most cases develop within the first 3 years, with 50% occurring within 10 months of starting lithium 3, 4
2. Initiate Levothyroxine While Continuing Lithium
The evidence strongly supports maintaining lithium therapy with thyroid hormone supplementation 1, 2, 5:
For Overt Hypothyroidism (elevated TSH + low free T4):
- Start levothyroxine at standard replacement doses
- Young healthy adults: Can start with full replacement doses 1
- Patients >50-60 years without coronary disease: Start with 50 µg daily 1
- Patients with known coronary disease: Start with 12.5-25 µg daily 1
For Subclinical Hypothyroidism (elevated TSH + normal free T4):
- TSH >10 mIU/L: Start levothyroxine 25-75 µg daily based on degree of TSH elevation 6, 1
- TSH 4.5-10 mIU/L: Monitor every 6-12 months; consider treatment trial if symptomatic, but evidence for benefit is limited 6
3. Dosing and Monitoring Protocol
Administration:
- Take levothyroxine with water 30-60 minutes before breakfast OR at bedtime 4 hours after last meal 1
- Avoid concurrent medications that interfere with absorption 1
Follow-up Testing:
- Recheck TSH 4-8 weeks after starting or adjusting levothyroxine 1
- Make dose adjustments in 12.5-25 µg increments 1
- Once stable, monitor TSH every 6-12 months 1
4. Do NOT Discontinue Lithium
This is critical: Hypothyroid patients responding well to lithium should continue medication combined with appropriate thyroxine substitution 2. The rationale:
- Lithium remains the gold standard for bipolar disorder prophylaxis 5
- Lithium reduces excessive mortality associated with affective disorders 5
- Thyroid dysfunction should not constitute an outright contraindication to lithium 5
- The psychiatric risks of stopping lithium typically outweigh the manageable thyroid effects
5. Special Consideration: Reversibility After Lithium Discontinuation
If lithium must be discontinued for other reasons, note that 41% of patients can successfully stop thyroid replacement therapy after lithium discontinuation 3. In such cases:
- Attempt thyroid replacement discontinuation after lithium has been stopped
- Monitor closely; hypothyroidism recurs early if it will recur at all 3
- Only 1 in 6 patients who stop thyroid replacement will need to restart it for overt hypothyroidism 3
Common Pitfalls to Avoid
Don't stop lithium reflexively: The psychiatric consequences typically outweigh the thyroid effects, which are readily treatable 2, 5
Don't undertreated based on "subclinical" label: TSH >10 mIU/L warrants treatment regardless of symptoms 6
Don't forget pre-existing risk factors: Middle-aged women and those with thyroid autoimmunity are at highest risk 2, 5, 4
Don't overlook lithium level optimization: Higher lithium levels are associated with increased hypothyroidism risk; levels >0.5028 mEq/L represent a threshold for increased risk 7, 8
Don't assume permanent thyroid dysfunction: If lithium is discontinued, many patients can stop thyroid replacement 3
Ongoing Surveillance
For patients continuing lithium 1, 9:
- Monitor TSH every 6 months during maintenance therapy 10
- More frequent monitoring (every 4-6 months) if TSH elevated or thyroid antibodies present 5
- Annual thyroid function testing is the minimum acceptable standard 5
- The FDA label specifically states that "where hypothyroidism occurs during lithium stabilization and maintenance, supplemental thyroid treatment may be used" 9
The key principle: Lithium-induced hypothyroidism is a manageable side effect that should not prevent continued use of this highly effective mood stabilizer 1, 2, 5.